The impact of frailty on outcomes for liver transplant recipients is gaining widespread attention in transplant programs around the world. In numerous studies, frailty has been associated with increased length of stay, increased hospitalizations, increased costs, and increased mortality. Frailty has even been shown to have as much of an impact on patient survival as a high MELD (Model for End Stage Liver Disease).
The COVID-19 pandemic has caused an unprecedented increase in the need for emergency and critical care services. People across the globe are experiencing heightened stress. Front-line workers, who have stressful jobs even during the calmest of times, are facing new challenges both at work and at home.
Cardiovascular disease is the leading cause of death in US women. However, many women present with atypical symptoms of cardiovascular disease risk. They often go untreated and are not seen again until a life-threatening cardiac event occurs. Researchers at Baylor Scott & White Medical Center – Temple, TX are participating in a clinical trial aimed at helping these women.
Clinical trials for new minimally invasive technologies have the potential for improved recovery times and reduced pain for patients with aortic arch conditions. Baylor Scott & White The Heart Hospital – Plano is the major center for clinical trials for diseases of the aorta in North Texas, and their work has put them at the forefront of minimally invasive therapies.
Researchers at Baylor Scott & White recently co-authored a paper published in CardioRenal Medicine addressing RAASi applications for acute heart failure patients.
